nodes	percent_of_prediction	percent_of_DWPC	metapath
Amphetamine—SLC6A3—malignant glioma	0.699	1	CbGaD
Amphetamine—CARTPT—telencephalic ventricle—malignant glioma	0.0237	0.182	CbGeAlD
Amphetamine—SLC18A2—telencephalic ventricle—malignant glioma	0.00805	0.062	CbGeAlD
Amphetamine—CARTPT—brainstem—malignant glioma	0.00641	0.0493	CbGeAlD
Amphetamine—SLC6A3—telencephalic ventricle—malignant glioma	0.00609	0.0469	CbGeAlD
Amphetamine—CARTPT—telencephalon—malignant glioma	0.00569	0.0438	CbGeAlD
Amphetamine—DRD2—telencephalic ventricle—malignant glioma	0.00448	0.0345	CbGeAlD
Amphetamine—CARTPT—medulla oblongata—malignant glioma	0.00447	0.0344	CbGeAlD
Amphetamine—CARTPT—spinal cord—malignant glioma	0.00399	0.0307	CbGeAlD
Amphetamine—TAAR1—central nervous system—malignant glioma	0.00323	0.0249	CbGeAlD
Amphetamine—CARTPT—central nervous system—malignant glioma	0.00323	0.0249	CbGeAlD
Amphetamine—CARTPT—cerebellum—malignant glioma	0.00316	0.0243	CbGeAlD
Amphetamine—CARTPT—brain—malignant glioma	0.00257	0.0198	CbGeAlD
Amphetamine—Tooth disorder—Temozolomide—malignant glioma	0.00255	0.045	CcSEcCtD
Amphetamine—Digestion impaired—Temozolomide—malignant glioma	0.00248	0.0437	CcSEcCtD
Amphetamine—SLC18A2—brainstem—malignant glioma	0.00218	0.0168	CbGeAlD
Amphetamine—Speech disorder—Carmustine—malignant glioma	0.00199	0.0351	CcSEcCtD
Amphetamine—Accidental injury—Carmustine—malignant glioma	0.00194	0.0341	CcSEcCtD
Amphetamine—SLC18A2—telencephalon—malignant glioma	0.00193	0.0149	CbGeAlD
Amphetamine—Speech disorder—Temozolomide—malignant glioma	0.00193	0.0339	CcSEcCtD
Amphetamine—Viral infection—Temozolomide—malignant glioma	0.00183	0.0323	CcSEcCtD
Amphetamine—SLC22A3—embryo—malignant glioma	0.00169	0.013	CbGeAlD
Amphetamine—SLC6A3—brainstem—malignant glioma	0.00165	0.0127	CbGeAlD
Amphetamine—MAOB—embryo—malignant glioma	0.00157	0.0121	CbGeAlD
Amphetamine—SLC18A2—medulla oblongata—malignant glioma	0.00152	0.0117	CbGeAlD
Amphetamine—SLC6A4—brainstem—malignant glioma	0.00151	0.0116	CbGeAlD
Amphetamine—SLC6A3—telencephalon—malignant glioma	0.00146	0.0113	CbGeAlD
Amphetamine—MAOB—brainstem—malignant glioma	0.00144	0.011	CbGeAlD
Amphetamine—SLC18A2—midbrain—malignant glioma	0.00139	0.0107	CbGeAlD
Amphetamine—Injury—Carmustine—malignant glioma	0.00135	0.0238	CcSEcCtD
Amphetamine—SLC6A4—telencephalon—malignant glioma	0.00134	0.0103	CbGeAlD
Amphetamine—SLC6A2—brainstem—malignant glioma	0.00133	0.0102	CbGeAlD
Amphetamine—MAOB—telencephalon—malignant glioma	0.00127	0.00981	CbGeAlD
Amphetamine—DRD2—brainstem—malignant glioma	0.00121	0.00932	CbGeAlD
Amphetamine—Affect lability—Temozolomide—malignant glioma	0.00118	0.0209	CcSEcCtD
Amphetamine—SLC6A2—telencephalon—malignant glioma	0.00118	0.00908	CbGeAlD
Amphetamine—DRD2—retina—malignant glioma	0.00117	0.009	CbGeAlD
Amphetamine—Mood swings—Temozolomide—malignant glioma	0.00114	0.0201	CcSEcCtD
Amphetamine—Pseudoephedrine—IL2—malignant glioma	0.00111	0.126	CrCbGaD
Amphetamine—SLC18A2—central nervous system—malignant glioma	0.0011	0.00846	CbGeAlD
Amphetamine—SLC22A5—retina—malignant glioma	0.00109	0.00838	CbGeAlD
Amphetamine—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.00108	0.0191	CcSEcCtD
Amphetamine—DRD2—telencephalon—malignant glioma	0.00108	0.00827	CbGeAlD
Amphetamine—SLC18A2—cerebellum—malignant glioma	0.00107	0.00827	CbGeAlD
Amphetamine—SLC6A3—midbrain—malignant glioma	0.00105	0.00808	CbGeAlD
Amphetamine—SLC6A3—spinal cord—malignant glioma	0.00102	0.00789	CbGeAlD
Amphetamine—MAOB—medulla oblongata—malignant glioma	0.001	0.00771	CbGeAlD
Amphetamine—Benzphetamine—POR—malignant glioma	0.000987	0.112	CrCbGaD
Amphetamine—SLC6A4—midbrain—malignant glioma	0.000963	0.00741	CbGeAlD
Amphetamine—CYP2A6—cerebellum—malignant glioma	0.000959	0.00738	CbGeAlD
Amphetamine—Erectile dysfunction—Temozolomide—malignant glioma	0.000957	0.0169	CcSEcCtD
Amphetamine—Depression—Carmustine—malignant glioma	0.000956	0.0168	CcSEcCtD
Amphetamine—Photosensitivity reaction—Temozolomide—malignant glioma	0.000948	0.0167	CcSEcCtD
Amphetamine—Weight decreased—Temozolomide—malignant glioma	0.00094	0.0166	CcSEcCtD
Amphetamine—SLC6A4—spinal cord—malignant glioma	0.000939	0.00723	CbGeAlD
Amphetamine—Urinary tract infection—Carmustine—malignant glioma	0.000932	0.0164	CcSEcCtD
Amphetamine—SLC6A2—medulla oblongata—malignant glioma	0.000927	0.00713	CbGeAlD
Amphetamine—Depression—Temozolomide—malignant glioma	0.000924	0.0163	CcSEcCtD
Amphetamine—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.000918	0.0162	CcSEcCtD
Amphetamine—MAOB—midbrain—malignant glioma	0.000915	0.00704	CbGeAlD
Amphetamine—Urinary tract infection—Temozolomide—malignant glioma	0.0009	0.0159	CcSEcCtD
Amphetamine—Diethylpropion—SLC6A3—malignant glioma	0.000896	0.102	CrCbGaD
Amphetamine—MAOB—spinal cord—malignant glioma	0.000893	0.00687	CbGeAlD
Amphetamine—SLC18A2—brain—malignant glioma	0.000873	0.00671	CbGeAlD
Amphetamine—SLC6A3—central nervous system—malignant glioma	0.000831	0.0064	CbGeAlD
Amphetamine—SLC6A3—cerebellum—malignant glioma	0.000813	0.00625	CbGeAlD
Amphetamine—SLC22A5—medulla oblongata—malignant glioma	0.000787	0.00605	CbGeAlD
Amphetamine—Erythema multiforme—Temozolomide—malignant glioma	0.000786	0.0139	CcSEcCtD
Amphetamine—SLC22A3—central nervous system—malignant glioma	0.000783	0.00602	CbGeAlD
Amphetamine—CYP2A6—brain—malignant glioma	0.000779	0.006	CbGeAlD
Amphetamine—DRD2—midbrain—malignant glioma	0.000772	0.00594	CbGeAlD
Amphetamine—SLC6A4—central nervous system—malignant glioma	0.000762	0.00586	CbGeAlD
Amphetamine—CYP2D6—brainstem—malignant glioma	0.000728	0.0056	CbGeAlD
Amphetamine—MAOB—central nervous system—malignant glioma	0.000724	0.00557	CbGeAlD
Amphetamine—SLC22A5—midbrain—malignant glioma	0.000719	0.00553	CbGeAlD
Amphetamine—MAOB—cerebellum—malignant glioma	0.000708	0.00545	CbGeAlD
Amphetamine—Tremor—Carmustine—malignant glioma	0.000702	0.0124	CcSEcCtD
Amphetamine—SLC22A5—spinal cord—malignant glioma	0.000702	0.0054	CbGeAlD
Amphetamine—Agitation—Carmustine—malignant glioma	0.000688	0.0121	CcSEcCtD
Amphetamine—Lisdexamfetamine—SLC6A3—malignant glioma	0.000679	0.0772	CrCbGaD
Amphetamine—Tremor—Temozolomide—malignant glioma	0.000678	0.012	CcSEcCtD
Amphetamine—SLC6A2—central nervous system—malignant glioma	0.000671	0.00516	CbGeAlD
Amphetamine—Agitation—Temozolomide—malignant glioma	0.000665	0.0117	CcSEcCtD
Amphetamine—Angioedema—Temozolomide—malignant glioma	0.000661	0.0117	CcSEcCtD
Amphetamine—SLC6A3—brain—malignant glioma	0.00066	0.00508	CbGeAlD
Amphetamine—Convulsion—Carmustine—malignant glioma	0.000649	0.0114	CcSEcCtD
Amphetamine—Hypertension—Carmustine—malignant glioma	0.000647	0.0114	CcSEcCtD
Amphetamine—CYP2D6—telencephalon—malignant glioma	0.000646	0.00497	CbGeAlD
Amphetamine—Palpitations—Temozolomide—malignant glioma	0.00064	0.0113	CcSEcCtD
Amphetamine—Chest pain—Carmustine—malignant glioma	0.000638	0.0112	CcSEcCtD
Amphetamine—Anxiety—Carmustine—malignant glioma	0.000635	0.0112	CcSEcCtD
Amphetamine—Convulsion—Temozolomide—malignant glioma	0.000627	0.0111	CcSEcCtD
Amphetamine—Hypertension—Temozolomide—malignant glioma	0.000625	0.011	CcSEcCtD
Amphetamine—SLC22A3—brain—malignant glioma	0.000622	0.00478	CbGeAlD
Amphetamine—Anxiety—Temozolomide—malignant glioma	0.000614	0.0108	CcSEcCtD
Amphetamine—DRD2—central nervous system—malignant glioma	0.000611	0.0047	CbGeAlD
Amphetamine—Infection—Carmustine—malignant glioma	0.000607	0.0107	CcSEcCtD
Amphetamine—SLC6A4—brain—malignant glioma	0.000605	0.00465	CbGeAlD
Amphetamine—Dry mouth—Temozolomide—malignant glioma	0.000603	0.0106	CcSEcCtD
Amphetamine—DRD2—cerebellum—malignant glioma	0.000597	0.0046	CbGeAlD
Amphetamine—Tachycardia—Carmustine—malignant glioma	0.000597	0.0105	CcSEcCtD
Amphetamine—Anaphylactic shock—Temozolomide—malignant glioma	0.000591	0.0104	CcSEcCtD
Amphetamine—Infection—Temozolomide—malignant glioma	0.000587	0.0103	CcSEcCtD
Amphetamine—Anorexia—Carmustine—malignant glioma	0.000583	0.0103	CcSEcCtD
Amphetamine—MAOB—brain—malignant glioma	0.000575	0.00443	CbGeAlD
Amphetamine—Hyperhidrosis—Temozolomide—malignant glioma	0.000571	0.0101	CcSEcCtD
Amphetamine—Anorexia—Temozolomide—malignant glioma	0.000563	0.00992	CcSEcCtD
Amphetamine—SLC22A5—cerebellum—malignant glioma	0.000556	0.00428	CbGeAlD
Amphetamine—Insomnia—Carmustine—malignant glioma	0.000553	0.00974	CcSEcCtD
Amphetamine—Dyspnoea—Carmustine—malignant glioma	0.000545	0.0096	CcSEcCtD
Amphetamine—Somnolence—Carmustine—malignant glioma	0.000543	0.00958	CcSEcCtD
Amphetamine—Insomnia—Temozolomide—malignant glioma	0.000534	0.00942	CcSEcCtD
Amphetamine—SLC6A2—brain—malignant glioma	0.000533	0.0041	CbGeAlD
Amphetamine—Decreased appetite—Carmustine—malignant glioma	0.000531	0.00937	CcSEcCtD
Amphetamine—Gastrointestinal disorder—Carmustine—malignant glioma	0.000528	0.0093	CcSEcCtD
Amphetamine—Dyspnoea—Temozolomide—malignant glioma	0.000527	0.00928	CcSEcCtD
Amphetamine—Somnolence—Temozolomide—malignant glioma	0.000525	0.00926	CcSEcCtD
Amphetamine—Constipation—Carmustine—malignant glioma	0.000523	0.00921	CcSEcCtD
Amphetamine—Dyspepsia—Temozolomide—malignant glioma	0.00052	0.00916	CcSEcCtD
Amphetamine—Decreased appetite—Temozolomide—malignant glioma	0.000514	0.00905	CcSEcCtD
Amphetamine—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00051	0.00899	CcSEcCtD
Amphetamine—Fatigue—Temozolomide—malignant glioma	0.000509	0.00898	CcSEcCtD
Amphetamine—Ephedrine—BCHE—malignant glioma	0.000509	0.0578	CrCbGaD
Amphetamine—Constipation—Temozolomide—malignant glioma	0.000505	0.0089	CcSEcCtD
Amphetamine—Gastrointestinal pain—Carmustine—malignant glioma	0.0005	0.00881	CcSEcCtD
Amphetamine—DRD2—brain—malignant glioma	0.000485	0.00373	CbGeAlD
Amphetamine—Body temperature increased—Carmustine—malignant glioma	0.000483	0.00852	CcSEcCtD
Amphetamine—Abdominal pain—Carmustine—malignant glioma	0.000483	0.00852	CcSEcCtD
Amphetamine—Gastrointestinal pain—Temozolomide—malignant glioma	0.000483	0.00851	CcSEcCtD
Amphetamine—Benzyl alcohol—CYP2B6—malignant glioma	0.000481	0.0546	CrCbGaD
Amphetamine—Phenylpropanolamine—SLC6A3—malignant glioma	0.000477	0.0542	CrCbGaD
Amphetamine—Urticaria—Temozolomide—malignant glioma	0.000469	0.00827	CcSEcCtD
Amphetamine—Abdominal pain—Temozolomide—malignant glioma	0.000467	0.00823	CcSEcCtD
Amphetamine—Body temperature increased—Temozolomide—malignant glioma	0.000467	0.00823	CcSEcCtD
Amphetamine—Selegiline—CYP2B6—malignant glioma	0.000461	0.0524	CrCbGaD
Amphetamine—SLC22A5—brain—malignant glioma	0.000452	0.00348	CbGeAlD
Amphetamine—Hypersensitivity—Carmustine—malignant glioma	0.00045	0.00794	CcSEcCtD
Amphetamine—Asthenia—Carmustine—malignant glioma	0.000439	0.00773	CcSEcCtD
Amphetamine—Hypersensitivity—Temozolomide—malignant glioma	0.000435	0.00767	CcSEcCtD
Amphetamine—Phentermine—SLC6A3—malignant glioma	0.000425	0.0483	CrCbGaD
Amphetamine—Asthenia—Temozolomide—malignant glioma	0.000424	0.00747	CcSEcCtD
Amphetamine—Diarrhoea—Carmustine—malignant glioma	0.000418	0.00737	CcSEcCtD
Amphetamine—Dextroamphetamine—SLC6A3—malignant glioma	0.000405	0.0461	CrCbGaD
Amphetamine—Dizziness—Carmustine—malignant glioma	0.000404	0.00712	CcSEcCtD
Amphetamine—Diarrhoea—Temozolomide—malignant glioma	0.000404	0.00712	CcSEcCtD
Amphetamine—Pseudoephedrine—SLC6A3—malignant glioma	0.000403	0.0458	CrCbGaD
Amphetamine—Dizziness—Temozolomide—malignant glioma	0.000391	0.00688	CcSEcCtD
Amphetamine—Vomiting—Carmustine—malignant glioma	0.000389	0.00685	CcSEcCtD
Amphetamine—Rash—Carmustine—malignant glioma	0.000385	0.00679	CcSEcCtD
Amphetamine—Dermatitis—Carmustine—malignant glioma	0.000385	0.00679	CcSEcCtD
Amphetamine—Headache—Carmustine—malignant glioma	0.000383	0.00675	CcSEcCtD
Amphetamine—Vomiting—Temozolomide—malignant glioma	0.000376	0.00662	CcSEcCtD
Amphetamine—Pseudoephedrine—TNF—malignant glioma	0.000374	0.0425	CrCbGaD
Amphetamine—Rash—Temozolomide—malignant glioma	0.000372	0.00656	CcSEcCtD
Amphetamine—Dermatitis—Temozolomide—malignant glioma	0.000372	0.00656	CcSEcCtD
Amphetamine—Headache—Temozolomide—malignant glioma	0.00037	0.00652	CcSEcCtD
Amphetamine—Nateglinide—PPARG—malignant glioma	0.000367	0.0417	CrCbGaD
Amphetamine—CYP2D6—central nervous system—malignant glioma	0.000367	0.00283	CbGeAlD
Amphetamine—Nausea—Carmustine—malignant glioma	0.000363	0.0064	CcSEcCtD
Amphetamine—CYP2D6—cerebellum—malignant glioma	0.000359	0.00276	CbGeAlD
Amphetamine—Benzphetamine—CYP2B6—malignant glioma	0.000352	0.04	CrCbGaD
Amphetamine—Nausea—Temozolomide—malignant glioma	0.000351	0.00618	CcSEcCtD
Amphetamine—Methamphetamine—SLC6A3—malignant glioma	0.000303	0.0344	CrCbGaD
Amphetamine—Benzphetamine—SLC6A3—malignant glioma	0.0003	0.0341	CrCbGaD
Amphetamine—CYP2D6—brain—malignant glioma	0.000292	0.00224	CbGeAlD
Amphetamine—Nateglinide—PTGS1—malignant glioma	0.000271	0.0308	CrCbGaD
Amphetamine—TAAR1—GPCR downstream signaling—CXCL8—malignant glioma	5.88e-05	0.000559	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—BDKRB2—malignant glioma	5.86e-05	0.000557	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—HES1—malignant glioma	5.81e-05	0.000552	CbGpPWpGaD
Amphetamine—SLC6A3—Transmembrane transport of small molecules—SLC5A5—malignant glioma	5.78e-05	0.00055	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—NCOR1—malignant glioma	5.77e-05	0.000549	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—SPHK1—malignant glioma	5.76e-05	0.000548	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—RAF1—malignant glioma	5.69e-05	0.000541	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—CYP2C18—malignant glioma	5.65e-05	0.000537	CbGpPWpGaD
Amphetamine—TAAR1—GPCR downstream signaling—IL2—malignant glioma	5.62e-05	0.000535	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—LATS1—malignant glioma	5.58e-05	0.000531	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—PIK3CB—malignant glioma	5.56e-05	0.000529	CbGpPWpGaD
Amphetamine—SLC6A3—Neuronal System—BRAF—malignant glioma	5.56e-05	0.000528	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—PDGFRA—malignant glioma	5.53e-05	0.000525	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—GSTT1—malignant glioma	5.4e-05	0.000513	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—SPP1—malignant glioma	5.37e-05	0.00051	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—CXCL8—malignant glioma	5.34e-05	0.000508	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—KNG1—malignant glioma	5.33e-05	0.000507	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—ASMT—malignant glioma	5.26e-05	0.0005	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—IL2—malignant glioma	5.11e-05	0.000485	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—TERT—malignant glioma	5.09e-05	0.000484	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—PTGS1—malignant glioma	5.06e-05	0.000481	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—PDGFB—malignant glioma	4.97e-05	0.000472	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—BCAN—malignant glioma	4.95e-05	0.00047	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—FGFR1—malignant glioma	4.94e-05	0.00047	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—CCR4—malignant glioma	4.87e-05	0.000463	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—HIF1A—malignant glioma	4.87e-05	0.000462	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—CAV1—malignant glioma	4.71e-05	0.000447	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—BCHE—malignant glioma	4.7e-05	0.000447	CbGpPWpGaD
Amphetamine—SLC6A3—Neuronal System—MDM2—malignant glioma	4.66e-05	0.000443	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—KDR—malignant glioma	4.65e-05	0.000442	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—SLC5A5—malignant glioma	4.64e-05	0.000441	CbGpPWpGaD
Amphetamine—SLC6A3—Neuronal System—RAF1—malignant glioma	4.64e-05	0.000441	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—GSTT1—malignant glioma	4.57e-05	0.000434	CbGpPWpGaD
Amphetamine—SLC6A4—Circadian rythm related genes—TP53—malignant glioma	4.56e-05	0.000433	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—F2—malignant glioma	4.52e-05	0.00043	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—FN1—malignant glioma	4.48e-05	0.000426	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—F2—malignant glioma	4.48e-05	0.000426	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—BAD—malignant glioma	4.43e-05	0.000421	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—CCR4—malignant glioma	4.42e-05	0.000421	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—NOTCH1—malignant glioma	4.38e-05	0.000417	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—CD80—malignant glioma	4.29e-05	0.000408	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—PIK3CG—malignant glioma	4.29e-05	0.000407	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—APC—malignant glioma	4.29e-05	0.000407	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—PTGS1—malignant glioma	4.28e-05	0.000407	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—EGF—malignant glioma	4.24e-05	0.000403	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—PTPN11—malignant glioma	4.21e-05	0.0004	CbGpPWpGaD
Amphetamine—SLC18A2—Transmembrane transport of small molecules—RAF1—malignant glioma	4.18e-05	0.000398	CbGpPWpGaD
Amphetamine—DRD2—Circadian rythm related genes—PTEN—malignant glioma	4.09e-05	0.000388	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—BRAF—malignant glioma	4.03e-05	0.000383	CbGpPWpGaD
Amphetamine—DRD2—G alpha (i) signalling events—CXCL8—malignant glioma	4.01e-05	0.000381	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—IDH2—malignant glioma	3.99e-05	0.000379	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—BCHE—malignant glioma	3.98e-05	0.000378	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—SLC5A5—malignant glioma	3.93e-05	0.000374	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—AKT2—malignant glioma	3.92e-05	0.000373	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—EGFR—malignant glioma	3.91e-05	0.000371	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—MDK—malignant glioma	3.77e-05	0.000358	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—PIK3CD—malignant glioma	3.77e-05	0.000358	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—CYP2B6—malignant glioma	3.75e-05	0.000356	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—GSTP1—malignant glioma	3.74e-05	0.000356	CbGpPWpGaD
Amphetamine—TAAR1—GPCR downstream signaling—PIK3CA—malignant glioma	3.73e-05	0.000355	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—KRAS—malignant glioma	3.69e-05	0.000351	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—CAT—malignant glioma	3.64e-05	0.000346	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—CXCR3—malignant glioma	3.62e-05	0.000344	CbGpPWpGaD
Amphetamine—SLC22A3—Transmembrane transport of small molecules—RAF1—malignant glioma	3.62e-05	0.000344	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—FGF2—malignant glioma	3.61e-05	0.000343	CbGpPWpGaD
Amphetamine—SLC22A5—Transmembrane transport of small molecules—RAF1—malignant glioma	3.61e-05	0.000343	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—DTX1—malignant glioma	3.6e-05	0.000342	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—COX8A—malignant glioma	3.47e-05	0.00033	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—F2—malignant glioma	3.45e-05	0.000328	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—NCOR1—malignant glioma	3.44e-05	0.000327	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—IDH1—malignant glioma	3.43e-05	0.000326	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—PIK3CA—malignant glioma	3.39e-05	0.000322	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—MDM2—malignant glioma	3.38e-05	0.000321	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—RAF1—malignant glioma	3.36e-05	0.00032	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—ERBB2—malignant glioma	3.33e-05	0.000316	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—SPHK1—malignant glioma	3.32e-05	0.000315	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—BDKRB2—malignant glioma	3.31e-05	0.000315	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—CXCR3—malignant glioma	3.29e-05	0.000313	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—PIK3CB—malignant glioma	3.28e-05	0.000312	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—CYP2C18—malignant glioma	3.25e-05	0.000309	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL8—malignant glioma	3.19e-05	0.000303	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—GSTP1—malignant glioma	3.17e-05	0.000301	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—CXCL8—malignant glioma	3.16e-05	0.0003	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—CAT—malignant glioma	3.08e-05	0.000293	CbGpPWpGaD
Amphetamine—TAAR1—GPCR downstream signaling—AKT1—malignant glioma	3.05e-05	0.00029	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—CASP3—malignant glioma	3.02e-05	0.000287	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—IL2—malignant glioma	3.02e-05	0.000287	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—KNG1—malignant glioma	3.01e-05	0.000286	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—BDKRB2—malignant glioma	3.01e-05	0.000286	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ASMT—malignant glioma	2.95e-05	0.000281	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—NCOR1—malignant glioma	2.91e-05	0.000276	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—SUFU—malignant glioma	2.86e-05	0.000272	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—MMP9—malignant glioma	2.85e-05	0.000271	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—PTEN—malignant glioma	2.84e-05	0.00027	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—HEY2—malignant glioma	2.82e-05	0.000268	CbGpPWpGaD
Amphetamine—SLC6A2—Transmembrane transport of small molecules—RAF1—malignant glioma	2.82e-05	0.000268	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—CAV1—malignant glioma	2.8e-05	0.000266	CbGpPWpGaD
Amphetamine—DRD2—Circadian rythm related genes—TP53—malignant glioma	2.79e-05	0.000265	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—BCAN—malignant glioma	2.77e-05	0.000264	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—AKT1—malignant glioma	2.77e-05	0.000263	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—GFAP—malignant glioma	2.76e-05	0.000262	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—KNG1—malignant glioma	2.74e-05	0.00026	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—SPHK1—malignant glioma	2.67e-05	0.000254	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—GSTT1—malignant glioma	2.63e-05	0.00025	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—HEY1—malignant glioma	2.61e-05	0.000248	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CCR4—malignant glioma	2.61e-05	0.000248	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—VEGFA—malignant glioma	2.56e-05	0.000244	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—PIK3CG—malignant glioma	2.55e-05	0.000243	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—HIST1H3B—malignant glioma	2.54e-05	0.000241	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—STAT3—malignant glioma	2.54e-05	0.000241	CbGpPWpGaD
Amphetamine—SLC6A3—Transmembrane transport of small molecules—RAF1—malignant glioma	2.49e-05	0.000237	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—PPARG—malignant glioma	2.46e-05	0.000234	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PTGS1—malignant glioma	2.46e-05	0.000234	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—CXCL8—malignant glioma	2.43e-05	0.000231	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—MMP3—malignant glioma	2.42e-05	0.00023	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—CAV1—malignant glioma	2.37e-05	0.000225	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—MYC—malignant glioma	2.36e-05	0.000224	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—JAG2—malignant glioma	2.32e-05	0.00022	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—EGFR—malignant glioma	2.31e-05	0.000219	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—BCHE—malignant glioma	2.29e-05	0.000218	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—SLC5A5—malignant glioma	2.26e-05	0.000215	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—PIK3CD—malignant glioma	2.24e-05	0.000213	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—IDH2—malignant glioma	2.24e-05	0.000213	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—KRAS—malignant glioma	2.18e-05	0.000207	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—PIK3CG—malignant glioma	2.16e-05	0.000205	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CYP2B6—malignant glioma	2.1e-05	0.0002	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—PPARG—malignant glioma	2.08e-05	0.000198	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—PIK3CA—malignant glioma	2e-05	0.00019	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—H3F3A—malignant glioma	1.96e-05	0.000186	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—PIK3CB—malignant glioma	1.96e-05	0.000186	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—F2—malignant glioma	1.95e-05	0.000185	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CXCR3—malignant glioma	1.94e-05	0.000185	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—PTGS2—malignant glioma	1.94e-05	0.000184	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—TP53—malignant glioma	1.94e-05	0.000184	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—IDH1—malignant glioma	1.92e-05	0.000183	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—PIK3CD—malignant glioma	1.9e-05	0.00018	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—YWHAE—malignant glioma	1.89e-05	0.00018	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—NTRK2—malignant glioma	1.89e-05	0.00018	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—FLT1—malignant glioma	1.88e-05	0.000179	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—DUSP6—malignant glioma	1.87e-05	0.000178	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—PIK3CG—malignant glioma	1.86e-05	0.000177	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—SPHK1—malignant glioma	1.86e-05	0.000177	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—JAG1—malignant glioma	1.85e-05	0.000176	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—NOTCH3—malignant glioma	1.84e-05	0.000175	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CYP2C18—malignant glioma	1.82e-05	0.000173	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—GSTP1—malignant glioma	1.82e-05	0.000173	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—FBXW7—malignant glioma	1.81e-05	0.000172	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—BDKRB2—malignant glioma	1.78e-05	0.000169	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—CAT—malignant glioma	1.77e-05	0.000169	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—F2—malignant glioma	1.77e-05	0.000168	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—AKT2—malignant glioma	1.7e-05	0.000162	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—PIK3CG—malignant glioma	1.69e-05	0.000161	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—PTEN—malignant glioma	1.69e-05	0.000161	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—NCOR1—malignant glioma	1.67e-05	0.000159	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—PTPN11—malignant glioma	1.66e-05	0.000158	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—PIK3CB—malignant glioma	1.65e-05	0.000157	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—NOTCH2—malignant glioma	1.65e-05	0.000157	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—PTGS2—malignant glioma	1.64e-05	0.000156	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—PIK3CD—malignant glioma	1.64e-05	0.000156	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—AKT1—malignant glioma	1.64e-05	0.000155	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—KNG1—malignant glioma	1.62e-05	0.000154	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—AKT2—malignant glioma	1.55e-05	0.000147	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—NTRK1—malignant glioma	1.54e-05	0.000146	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—PIK3CD—malignant glioma	1.49e-05	0.000141	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GSTT1—malignant glioma	1.47e-05	0.00014	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—MMP3—malignant glioma	1.43e-05	0.000136	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—PTEN—malignant glioma	1.43e-05	0.000136	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—PIK3CB—malignant glioma	1.43e-05	0.000136	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CDKN2B—malignant glioma	1.42e-05	0.000135	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PTGS1—malignant glioma	1.38e-05	0.000131	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PTK2—malignant glioma	1.38e-05	0.000131	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—CXCL8—malignant glioma	1.37e-05	0.00013	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—CAV1—malignant glioma	1.37e-05	0.00013	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—HES1—malignant glioma	1.35e-05	0.000129	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—NCOR1—malignant glioma	1.35e-05	0.000128	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—RAF1—malignant glioma	1.33e-05	0.000126	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—IL2—malignant glioma	1.31e-05	0.000125	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—PIK3CB—malignant glioma	1.3e-05	0.000123	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PDGFRA—malignant glioma	1.29e-05	0.000123	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—BCHE—malignant glioma	1.28e-05	0.000122	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—SLC5A5—malignant glioma	1.27e-05	0.000121	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—SPP1—malignant glioma	1.25e-05	0.000119	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—CXCL8—malignant glioma	1.25e-05	0.000118	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PIK3CG—malignant glioma	1.24e-05	0.000118	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PPARG—malignant glioma	1.2e-05	0.000114	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—PIK3CA—malignant glioma	1.19e-05	0.000113	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—IL2—malignant glioma	1.19e-05	0.000113	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—TERT—malignant glioma	1.19e-05	0.000113	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PDGFB—malignant glioma	1.16e-05	0.00011	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—FGFR1—malignant glioma	1.15e-05	0.00011	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—HIF1A—malignant glioma	1.13e-05	0.000108	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CAV1—malignant glioma	1.1e-05	0.000104	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PIK3CD—malignant glioma	1.09e-05	0.000104	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—KDR—malignant glioma	1.09e-05	0.000103	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—F2—malignant glioma	1.04e-05	9.93e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—FN1—malignant glioma	1.04e-05	9.93e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—BAD—malignant glioma	1.03e-05	9.81e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—NOTCH1—malignant glioma	1.02e-05	9.72e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GSTP1—malignant glioma	1.02e-05	9.72e-05	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—PIK3CA—malignant glioma	1.01e-05	9.59e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CD80—malignant glioma	1e-05	9.52e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PIK3CG—malignant glioma	1e-05	9.5e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—APC—malignant glioma	1e-05	9.5e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CAT—malignant glioma	9.94e-06	9.45e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—EGF—malignant glioma	9.88e-06	9.39e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PTPN11—malignant glioma	9.82e-06	9.34e-05	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—AKT1—malignant glioma	9.74e-06	9.26e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PIK3CB—malignant glioma	9.53e-06	9.06e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PTGS2—malignant glioma	9.44e-06	8.98e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—BRAF—malignant glioma	9.4e-06	8.93e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—NCOR1—malignant glioma	9.39e-06	8.93e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—AKT2—malignant glioma	9.15e-06	8.69e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—EGFR—malignant glioma	9.11e-06	8.66e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PIK3CD—malignant glioma	8.79e-06	8.35e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—PIK3CA—malignant glioma	8.7e-06	8.27e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—KRAS—malignant glioma	8.6e-06	8.18e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—FGF2—malignant glioma	8.41e-06	8e-05	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—AKT1—malignant glioma	8.24e-06	7.83e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PTEN—malignant glioma	8.23e-06	7.83e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—PIK3CA—malignant glioma	7.9e-06	7.51e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—MDM2—malignant glioma	7.87e-06	7.48e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—RAF1—malignant glioma	7.85e-06	7.46e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—ERBB2—malignant glioma	7.76e-06	7.38e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PIK3CB—malignant glioma	7.66e-06	7.28e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CAV1—malignant glioma	7.66e-06	7.28e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CXCL8—malignant glioma	7.36e-06	7e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—AKT1—malignant glioma	7.11e-06	6.76e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CASP3—malignant glioma	7.04e-06	6.7e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—IL2—malignant glioma	7.03e-06	6.69e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PIK3CG—malignant glioma	6.97e-06	6.63e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PPARG—malignant glioma	6.73e-06	6.4e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—MMP9—malignant glioma	6.66e-06	6.33e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PTEN—malignant glioma	6.62e-06	6.29e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—AKT1—malignant glioma	6.46e-06	6.14e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PIK3CD—malignant glioma	6.13e-06	5.83e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—VEGFA—malignant glioma	5.98e-06	5.68e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—STAT3—malignant glioma	5.92e-06	5.63e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PIK3CA—malignant glioma	5.81e-06	5.52e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—MYC—malignant glioma	5.5e-06	5.23e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—EGFR—malignant glioma	5.38e-06	5.11e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PIK3CB—malignant glioma	5.34e-06	5.08e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PTGS2—malignant glioma	5.29e-06	5.03e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—KRAS—malignant glioma	5.08e-06	4.83e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—AKT1—malignant glioma	4.75e-06	4.51e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PIK3CA—malignant glioma	4.67e-06	4.44e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PTEN—malignant glioma	4.62e-06	4.39e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—TP53—malignant glioma	4.52e-06	4.29e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—AKT1—malignant glioma	3.81e-06	3.63e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PIK3CA—malignant glioma	3.26e-06	3.1e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—AKT1—malignant glioma	2.66e-06	2.53e-05	CbGpPWpGaD
